Discontinuation report BYETTA

Last updated on 2022-02-02 History
Report ID 154103
Drug Identification Number 02361817
Brand name BYETTA
Common or Proper name exenatide injection
Company Name ASTRAZENECA CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) EXENATIDE
Strength(s) 10MCG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size single 2.4 mL prefilled pen (10 mcg per dose) per carton
ATC code A10BJ
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-01-31
Actual discontinuation date 2022-01-31
Remaining supply date 2022-02-28
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-02-02 French Compare
v2 2022-02-02 English Compare
v1 2022-02-02 English Compare

Showing 1 to 3 of 3